Alan D Watson

Title: Alan D Watson: Innovator in Radiopharmaceuticals

Introduction

Alan D Watson is a notable inventor based in Andover, MA (US), recognized for his contributions to the field of radiopharmaceuticals. He holds 2 patents that focus on innovative compounds used in medical imaging.

Latest Patents

Watson's latest patents include the development of ester-substituted diaminedithiols and radiolabeled complexes thereof. These radiopharmaceuticals consist of a lipophilic, charge neutral radionuclide complex of a diaminedithiol ligand, which features 1-4 ester groups. The formula --A--COOR describes the structure, where A represents a straight or branched chain alkylene of 0-10 carbon atoms, and R is an alkyl group of 1-10 carbon atoms. These compounds are particularly useful in radioimaging brain perfusion in primates. Additionally, Watson's patents provide ester-substituted diaminedithiols in sterile, pharmaceutically acceptable forms, along with kits that include sterile, non-pyrogenic reducing agents for reducing preselected radionuclides, with Technetium-99m being a preferred radionuclide.

Career Highlights

Alan D Watson is associated with the Dupont Merck Pharmaceutical Company, where he has made significant strides in pharmaceutical innovation. His work has contributed to advancements in medical imaging technologies, enhancing the ability to visualize brain perfusion.

Collaborations

Throughout his career, Watson has collaborated with esteemed colleagues such as Paul L Bergstein and Edward H Cheesman, further enriching his research and development efforts in the pharmaceutical field.

Conclusion

Alan D Watson's innovative work in the realm of radiopharmaceuticals showcases his commitment to advancing medical imaging technologies. His patents reflect a significant contribution to the field, underscoring the importance of innovation in healthcare.